Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Politics of Emotional Shockwaves
This interdisciplinary volume brings together specialists from different backgrounds to deliver expert views on the relationship between morality and emotion, putting a special emphasis on issues related to emotional shocks. One of the distinctive aspects of social existence today is our subjection to traumatic events on a global scale, and our subsequent embodiment of the emotional responses these events provoke. Covering various methodological angles, the contributors ensure careful and heterogeneous reflection on this delicate topic. With eleven original essays, the collection spans a wide variety of fields from philosophy and literary theory, to the visual arts, history, and psychology. ...
Doing Business 2013
Tenth in a series of annual reports comparing business regulation in 185 economies, Doing Business 2013 measures regulations affecting 11 areas of everyday business activity: starting a business, dealing with construction permits, getting electricity, registering property, getting credit, protecting investors, paying taxes, trading across borders, enforcing contracts, closing a business, and employing workers. The report updates all indicators as of June 1, 2012, ranks economies on their overall “ease of doing business”, and analyzes reforms to business regulation – identifying which economies are strengthening their business environment the most. The Doing Business reports illustrate ...
Doing Business 2012
Ninth in a series of annual reports comparing business regulations in 183 economies, Doing Business 2012 measures regulations affecting 11 areas of everyday business activity: ? starting a business ? dealing with construction permits ? employing workers ? registering property ? getting credit ? protecting investors ? paying taxes ? trading across borders ? enforcing contracts ? closing a business ? getting electricity The report updates all indicators as of June 1, 2011, ranks countries on their overall "ease of doing business", and analyzes reforms to business regulation-identifying which countries are strengthening their business environment the most. Doing Business 2012 includes a new set...
ACESSO À SAÚDE NO BRASIL: Percursos da Universalização
Todos os cidadãos brasileiros têm direito a receber atendimento de saúde adequado e gratuito, independentemente de sua condição social, econômica, gênero, raça ou etnia. Este livro é uma iniciativa inédita no Brasil, busca trazer reflexões e apresentar estratégias para contribuir e promover o debate em torno do direito à saúde como um direito humano fundamental e universal.
Doing Business 2019
Sixteenth in a series of annual reports comparing business regulation in 190 economies, Doing Business 2019 measures aspects of regulation affecting 10 areas of everyday business activity: • Starting a business • Dealing with construction permits • Getting electricity • Registering property • Getting credit • Protecting minority investors • Paying taxes • Trading across borders • Enforcing contracts • Resolving insolvency These areas are included in the distance to frontier score and ease of doing business ranking. Doing Business also measures features of labor market regulation, which is not included in these two measures. This edition also presents the findings of the p...
The International Corporate 1000
The International Corporate 1000 represents a joint venture between Monitor Publishing Com pany of Washington, DC, and Graham & Trotman Limited of London. Monitor Publishing Company is well known as the publisher of The Federal Yellow Book, The Congressional Yellow Book, and The Corporate 1000. Graham & Trotman's annual directories providing data on the major companies in many parts of the world are equally established. The two publishing companies have pooled their expertise in this joint venture to research, compile and publish The International Corporate 1000, A Directory o/Who Runs The World's 1000 Leading Corporations. The directory was designed to help you identify and contact the seni...
Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning
Leishmaniases are a group of tropical diseases that affect millions of people worldwide. They are considered neglected diseases prevalent in emerging countries in Latin America, West Africa, and Southeast Asia and still occurring in Mediterranean countries. There is no human vaccine available to prevent and control the disease infection. For the last 70 years, the available chemotherapy has been constituted by first-line (pentavalent antimonials) and second-line drugs (amphotericin B, pentamidine, paramomycin, and miltefosine). Its route of administration is difficult, the treatment is long, and its efficiency varies depending on the parasite species and clinical manifestations, which results in the emergence of resistant cases. Moreover, they present high toxicity to patients, and even some less toxic formulations available, are still expensive for the poorest countries’ vulnerable populations. This often leads to abandonment and failure of treatment. The medical-scientific community is facing difficulties to overcome these issues with new suitable therapies, and the identification of new drug targets. So, it means that efforts to identify new strategies must continue.
